VIPR1 and Familial prostate cancer: In the same way as ADRB2, VIP receptors VIPR1 and VIPR2 are expressed in prostate cancer and engage PKA/pS75BAD mechanism to inhibit apoptosis in prostate cancer cells [78,79].